Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: Summary of WHO recommendations

PLoS Medicine

Volumn 8, Issue 11, 2011, Pages

  Dua, Tarun ^a   Barbui, Corrado ^b   Clark, Nicolas ^a   Fleischmann, Alexandra ^a   Poznyak, Vladimir ^a   van Ommeren, Mark ^a   Yasamy, M Taghi ^a   Ayuso Mateos, Jose Luis ^c   Birbeck, Gretchen L ^d,v   Drummond, Colin ^e   Freeman, Melvyn ^f   Giannakopoulos, Panteleimon ^g,w   Levav, Itzhak ^h   Obot, Isidore S ⁱ   Omigbodun, Olayinka ^j   Patel, Vikram ^k,x   Phillips, Michael ^l,y   Prince, Martin ^e   Rahimi Movaghar, Afarin ^m   Rahman, Atif ⁿ   Sander, Josemir W ^o,z   Saunders, John B ^p   Servili, Chiara ^q   Rangaswamy, Thara ^r   Unützer, Jürgen ^s   Ventevogel, Peter ^t   Vijayakumar, Lakshmi ^u   Thornicroft, Graham ^e   Saxena, Shekhar ^a   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d East Lansing   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NATIONAL DEPARTMENT OF HEALTH   (South Africa)

^g UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^h MINISTRY OF HEALTH   (Israel)

ⁱ UNIVERSITY OF UYO   (Nigeria)

^j UNIVERSITY OF IBADAN   (Nigeria)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^l SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^m TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^o UNIVERSITY COLLEGE LONDON   (United Kingdom)

^p University of Sydney   (Australia)

^q WHO Eritrea   (Eritrea)

^r SCHIZOPHRENIA RESEARCH FOUNDATION   (India)

^s UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^t Department of Research and Development   (Netherlands)

^u The Voluntary Health Services Chennai   (India)

^v Chikankata Hospital   (Zambia)

^w LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^x Sangath   (India)

^y EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^z STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLOZAPINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; LITHIUM; MEMANTINE; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ARTICLE; BEHAVIOR DISORDER; BIPOLAR MANIA; COGNITIVE THERAPY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG DEPENDENCE; ECONOMIC EVALUATION; EMOTIONALITY; EPILEPSY; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; MENTAL DISEASE; MENTAL HEALTH CARE; METHODOLOGY; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PREVALENCE; PROGRAM DEVELOPMENT; PSYCHOEDUCATION; PSYCHOSIS; PUBLIC HEALTH SERVICE; RELAXATION TRAINING; SEIZURE; SOCIOECONOMICS; SUBSTANCE ABUSE; WORLD HEALTH ORGANIZATION; ADDICTION; DEVELOPING COUNTRY; HEALTH CARE PLANNING; INCOME; MENTAL HEALTH SERVICE; PATIENT CARE; STANDARD; UTILIZATION REVIEW;

DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HUMANS; INCOME; MENTAL DISORDERS; MENTAL HEALTH SERVICES; NERVOUS SYSTEM DISEASES; PATIENT CARE MANAGEMENT; SUBSTANCE-RELATED DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 82455219427     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001122     Document Type: Article

References (36)

1. World Health Organization (2008) Scaling up care for mental, neurological, and substance use disorders. Available: http://www.who.int/mental_health/mhgap_final_english.pdf. Accessed 10 October 2011.
2. Prince M, Patel V, Saxena S, Maj M, Maselko J, et al. (2007) No health without mental health. Lancet 370: 859-877.
3. Saxena S, Thornicroft G, Knapp M, Whiteford H, (2007) Resources for mental health: scarcity, inequity and inefficiency. Lancet 370: 878-889.
4. Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, et al. (2007) Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 370: 991-1005.
5. Jacob KS, Sharan P, Mirza I, Garrido-Cumbrera M, Seedat S, et al. (2007) Mental health systems in countries: where are we now? Lancet 370: 1061-1077.
6. Saraceno B, van Ommeren M, Batniji R, Cohen A, Gureje O, et al. (2007) Barriers to improvement of mental health services in low-income and middle-income countries. Lancet 370: 1164-1174.
7. Chisholm D, Flisher AJ, Lund C, Patel V, Saxena S, et al. (2007) Scale up services for mental disorders: a call for action. Lancet 370: 1241-1252.
8. World Health Organization (2008) The global burden of disease: 2004 update. Available: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed 10 October 2011.
9. World Health Organization (2010) Packages of interventions for family planning, safe abortion care, maternal, newborn and child health. Available: http://whqlibdoc.who.int/hq/2010/WHO_FCH_10.06_eng.pdf. Accessed 10 October 2011.
10. Collins PY, Patel V, Joestl SS, March D, Insel TR, et al. (2011) Grand challenges in global mental health. Nature 475: 27-30.
11. Patel V, Thornicroft G, (2009) Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries. PLoS Med 6: e1000160 doi:10.1371/journal.pmed.1000160.
12. Barbui C, Dua T, van Ommeren M, Yasamy MT, Fleischmann A, et al. (2010) Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Med 7: e1000322 doi:10.1371/journal.pmed.1000322.
13. Bloomrosen M, Detmer DE, (2010) Informatics, evidence-based care, and research; implications for national policy: a report of an American Medical Informatics Association health policy conference. J Am Med Inform Assoc 17: 115-123.
14. Weinmann S, Koesters M, Becker T, (2007) Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatr Scand 115: 420-433.
15. Knaup C, Koesters M, Schoefer D, Becker T, Puschner B, (2009) Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. Br J Psychiatry 195: 15-22.
16. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8: iii-iv, 1-72.
17. Tansella M, Thornicroft G, (2009) Implementation science: understanding the translation of evidence into practice. Br J Psychiatry 195: 283-285.
18. World Health Organization (2010) mhGAP intervention guide for for mental, neurological, and substance use disorders in non-specialized settings. Available: http://www.who.int/mental_health/evidence/mhGAP_intervention_guide/en/index.html. Accessed 10 October 2011.
19. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S, (2004) Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 184: 393-403.
20. Chisholm D, WHO-CHOICE (2005) Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia 46: 751-759.
21. WHO (2011) mhGAP newsletter. June 2011. Available: http://www.who.int/mental_health/mhGAP_nl__jun2011_en.pdf. Accessed 15 October 2011.
22. University of Cape Town (11 February 2011) New project to PRIME mental health services. Available: http://www.uct.ac.za/print/dailynews/?id=7691. Accessed 10 October 2011.
23. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M, (2011) Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198: 11-16, sup 1.
24. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, et al. (2008) Initial severity and antidepressant benefits: a metaanalysis of data submitted to the Food and Drug Administration. PLoS Med 5: e45 doi:10.1371/journal.pmed.0050045.
25. Rathbone J, Soares-Weiser K, (2006) Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Syst Rev 4: CD003727.
26. Fowle AJ, Binnie CD, (2000) Uses and abuses of the EEG in epilepsy. Epilepsia 41 (Suppl 3): S10-S18.
27. Engel J Jr, (1984) A practical guide for routine EEG studies in epilepsy. J Clin Neurophysiol 1: 109-142.
28. Benbadis SR, Tatum WO, (2003) Overintepretation of EEGs and misdiagnosis of epilepsy. J Clin Neurophysiol 20: 42-44.
29. Rosner S, Leucht S, Lehert P, Soykaet M, (2008) Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Psychopharmacology 22: 11-23.
30. Ghuman JK, Arnold LE, Anthony BJ, (2008) Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol 18: 413-447.
31. NICE (2009) Attention deficit hyperactivity disorder. The NICE guideline on diagnosis and management of ADHD in children, young people and adults. Section 7.2.14. From evidence to recommendations: psychological interventions for children and young people with ADHD. NICE technology appraisal 72 London National Institute for Health and Clinical Excellence.
32. King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, et al. (2006) A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess 10: 1-162.
33. Banerjee S, (2009) The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. London: Department of Health. Available: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108302.pdf. Accessed 10 October 2011.
34. Beautrais AL, Joyce PR, Mulder RT, Fergusson DM, Deavoll BJ, et al. (1996) Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 153: 1009-1014.
35. Lejoyeux M, Huet F, Claudon M, Fichelle A, Casalino E, et al. (2008) Characteristics of suicide attempts preceded by alcohol consumption. Arch Suicide Res 12: 30-38.
36. Denis C, Lavie E, Fatseas M, Auriacombe M, (2006) Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Systematic Reviews 3 pp. CD005336.